Update on the management of overactive bladder.
Ther Adv Urol
; 13: 17562872211039034, 2021.
Article
em En
| MEDLINE
| ID: mdl-34484427
ABSTRACT
Overactive bladder (OAB) syndrome is a common condition characterised by urinary urgency, with or without urgency incontinence, frequency and nocturia, in the absence of any other pathology. Clinical diagnosis is based upon patient self-reported symptomology. Currently there is a plethora of treatments available for the management of OAB. Clinical guidelines suggest treatment via a multidisciplinary pathway including behavioural therapy and pharmacotherapy, which can be commenced in primary care, with referral to specialist services in those patients refractory to these treatments. Intradetrusor botulinum A and sacral neuromodulation provide safe and efficacious management of refractory OAB. Percutaneous tibial nerve stimulation and augmentation cystoplasty remain available and efficacious in a select group of patients. Unfortunately, there remains a high rate of patient dissatisfaction and discontinuation in all treatments and thus there remains a need for emerging therapies in the management of OAB.
Texto completo:
1
Bases de dados:
MEDLINE
Tipo de estudo:
Guideline
Idioma:
En
Revista:
Ther Adv Urol
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Reino Unido